The fall edition of LVI Visions showcases Kim's strong leadership in the Dental Laboratory industry. This magazine is published by LVI with the goal to spread the word on Neuromuscular Dentistry, and to inspire doctors across the country through encouraging and thought-provoking articles. Additionally in the Journal of Dental Technology, she has been featured the article titled as "Who is Hot in 2012," which captures the vision of five Dental Industry leaders in an intimate interview that also reveals their creativity, passion and determination.
View The Journal of Dental Technology's Feature / View Kim's Article in LVI Visions
------------
For immmediate release!
Dublin, California, January 4, 2012—Dental Technologies, Inc. (DTI), one of the largest networks of dental laboratories in North America, today announced the appointment of Laura Sheppard, CDT to the position of
Sr. Director of Regulatory and Compliance.
Prior to joining DTI, Mrs. Sheppard worked for Dental Services Group where she held a variety of senior management positions including Manager of Davis Dental Laboratory’s Orthodontic and Therapy departments, Director of Training & Education and most recently, Director of Quality and Compliance.
“We are very proud to have added someone with Laura’s experience to our Management Team,” said Kimberly L. Bradshaw, President and CEO of DTI. “With over 20 years of industry experience, she has a proven track record of designing and implementing successful quality control strategies that support clinicians’ goals and expectations.”
Laura is very active in the Dental Technology community currently serving as Chairman of NBC (National Board for Certification in Dental Technology) and is an NADL Trustee. Additionally, she’s well published having written numerous articles for JDT, IDT and LMT. In September of 2011, she was named as one of the Top 25 Women in Dentistry by Dental Products Report.
Mrs Sheppard added, “I am thrilled to be joining the leadership team at DTI. They have a long-standing reputation for high-end quality restorations, outstanding customer service and employee care.” As Sr. Director of Regulatory and Compliance, Laura will be will responsible for the Company’s Compliance and Quality programs as well as helping with several key strategic initiatives.
------------
DTI | DENTAL TECHNOLOGIES INC APPOINTS LEE CULP, CDT CHIEF TECHNOLOGY OFFICER Dublin, California, March 18, 2010—Dental Technologies, Inc. (DTI), one of the largest networks of dental laboratories in North America, today announced the appointment of Lee Culp, CDT to the position of Chief Technology Officer (CTO).
Mr. Culp brings more than 30 years of laboratory and technology experience to DTI. Prior to joining the company, he served as Vice-President of Dental Technologies at D4D Technologies, where he guided the development of a variety of technologies for use in both dental practices and dental laboratories.
“We are very pleased to have Lee join the company,” said Kimberly L. Bradshaw, President and CEO of DTI. “For years Lee has been an advocate for advancing technology in our industry and has been closely involved in its development. He shares our vision of the convergence of technology, quality and aesthetics in the dental laboratory industry and will play an integral role in leveraging this throughout our network.”
Mr. Culp added, “DTI's foundation for excellence in aesthetics, function, and customer service combined with their corporate commitment to digital technology keeps them at the forefront of dentistry and the dental laboratory profession. I am very excited about this opportunity to become part of the DTI team and assist in their continued growth and success.”
------------
JEFFREY ZELLMER NAMED CHIEF FINANCIAL OFFICER OF DTI (DENTAL TECHNOLOGIES, INC.) Dublin, California, March 24, 2010—Dental Technologies, Inc. (DTI), a network of high-quality, full-service dental laboratories located throughout North America, today announced the appointment of Jeffrey Zellmer to the position of Chief Financial Officer (CFO).
Mr. Zellmer has over 25 years of financial executive experience, including five years as CFO of publicly-traded Silicon Graphics, Inc. Most recently, he was Vice President of Finance for Lam Research Corporation, a publicly-traded technology company.
“We are very excited to have added someone of Jeff’s caliber to our Executive Team,” said Kimberly L. Bradshaw, President and CEO of DTI. “He has a strong history of building high-performing finance teams and has a demonstrated track record of building and maintaining financial and operational controls in high-growth corporate environments. Jeff also brings deep experience in financial planning and analysis.”
As CFO of DTI, Mr. Zellmer will be responsible for building an Accounting, Finance and Information Technology organization at DTI's headquarters in Dublin, California. Additionally, he will lead the transitions of these functions from a shared-services model currently located in another state.
Mr. Zellmer’s appointment follows the recent announcement that Lee Culp, CDT would join the company as Chief Technology Officer. Ms. Bradshaw commented, “Jeff and Lee will be instrumental in strengthening our management team, and they share our commitment to delivering customer satisfaction, driving growth and becoming the industry’s preeminent leader in the world of digital dentistry.”
NEW YORK, New York, VANCOUVER, Canada, and DUBLIN, California, March 12, 2007 /PRNewswire/ -- (“DTI” or “Micro”) by its portfolio company, DTI | Dental Technologies Inc. (“DTI”). DTI is the world’s leading cosmetic dentistry laboratory and maker of industry-leading MACVENEERS™. In the past 42 years, it has developed strong relationships with the nation’s most-prominent cosmetic dentists and is renowned for supplying award-winning, custom-manufactured restorative, reconstructive and cosmetic dental products such as crowns, bridges, veneers, implants, and dentures. Prior to this transaction, DTI had been a portfolio company of Riverside Partners since 2001. Terms of the transaction were not disclosed.
“The dental market represents one of the fastest growing sectors in the medical technology industry,” stated John H. Foster, Chairman of the Board of DTI and Chairman and Managing Director of HealthpointCapital. “The dental laboratory industry is a primary beneficiary of the public’s increasing interest in and willingness to pay for improved dental function and aesthetics. We were particularly attracted to DTI because of its strong brand, the depth of its management team and staff, and the relationships it has built through unparalleled service to cosmetically-oriented dentists.
The combination of MicroDental and DTI will create significant value because of its increased ability to utilize the latest in technology and provide continuing education to its technicians and dentists, while maintaining the service levels our clients expect.”
DTI is the world’s largest and most advanced cosmetic dental laboratory, setting the industry standard for innovation and quality for more than 40 years. DTI works closely with leading manufacturers, cosmetic dentists and professional organizations to help develop new materials, dental procedures and meaningful continuing educational opportunities for dental industry professionals. The company holds numerous patents, and many of the procedures DTI has developed have become industry best practices. DTI employs over 900 people.
Headquartered in Dublin, CA, DTI custom designs and fabricates crowns, bridges, dentures, cosmetic appliances and orthodontic appliances for its customers, dentists serving patients in need of restorative and cosmetic dentistry. DTI was founded in 1997 and has grown into one of the largest dental laboratory companies in the world with over 400 employees and a network of 16 labs in Canada and the United States. Consistency, quality, and communication are the cornerstones of success for each of DTI's labs and enable DTI to deliver “Peace of Mind” to its clientele.
HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on orthopedic and the broadly based musculoskeletal businesses, the fastest growing segment within the medical device industry. Our cumulative 70 years of experience in healthcare technology, research and private investing enable us to help our clients capitalize on the explosive growth and unique investment opportunities in this sector. HealthpointCapital has approximately $600 million of institutional capital.